| |
| |
|
| Insider
Information: |
Usman Nassim |
| Relationship: |
|
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,636 |
|
|
Indirect Shares
|
640 |
|
|
| Direct
Value |
$836 |
|
|
|
Indirect Value
|
$327 |
|
|
| Total
Shares |
2,276 |
|
|
| Total
Value |
$1,164 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -34.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
|
2024-05-01 |
1,636 |
2024-05-01 |
640 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GYRE |
Gyre Therapeutics |
|
• • – |
2024-05-01 |
4 |
AS |
$13.86 |
$282,577 |
D/D |
(20,000) |
1,636 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
|
• • – |
2024-05-01 |
4 |
OE |
$6.93 |
$138,600 |
D/D |
20,000 |
21,636 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
|
• • – |
2024-04-01 |
4 |
AS |
$16.15 |
$323,000 |
D/D |
(20,000) |
1,636 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
|
• • – |
2024-04-01 |
4 |
OE |
$6.93 |
$138,600 |
D/D |
20,000 |
21,636 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
|
• • – |
2024-03-15 |
4 |
AS |
$17.26 |
$345,200 |
D/D |
(20,000) |
1,636 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
|
• • – |
2024-03-15 |
4 |
OE |
$6.93 |
$138,600 |
D/D |
20,000 |
21,636 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2022-08-09 |
4 |
B |
$0.47 |
$1,528 |
D/D |
3,250 |
24,541 |
2.73 |
% |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2022-02-09 |
4 |
B |
$0.46 |
$1,495 |
D/D |
3,250 |
21,291 |
2.73 |
% |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2021-08-09 |
4 |
B |
$3.62 |
$3,139 |
D/D |
867 |
18,041 |
2.73 |
% |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2021-04-05 |
4 |
OE |
$4.63 |
$23,150 |
D/D |
5,000 |
17,174 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2021-02-09 |
4 |
B |
$4.81 |
$2,799 |
D/D |
582 |
12,174 |
2.73 |
% |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2020-08-10 |
4 |
B |
$4.81 |
$2,799 |
D/D |
582 |
11,592 |
2.73 |
% |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2020-03-13 |
4 |
B |
$3.91 |
$15,647 |
D/D |
4,000 |
11,010 |
2.81 |
% |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2020-02-10 |
4 |
A |
$6.23 |
$2,679 |
D/D |
430 |
7,010 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2019-08-12 |
4 |
A |
$6.51 |
$2,689 |
D/D |
413 |
6,580 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2019-05-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,400 |
8,456 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2019-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,400 |
6,167 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2019-05-21 |
4 |
OE |
$4.63 |
$20,372 |
D/D |
4,400 |
10,567 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2019-02-11 |
4 |
A |
$7.04 |
$2,464 |
D/D |
350 |
6,167 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2019-01-31 |
4 |
OE |
$4.63 |
$26,525 |
D/D |
5,729 |
11,041 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2018-04-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
88 |
4,144 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2018-04-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
88 |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2018-04-04 |
4 |
OE |
$4.63 |
$407 |
D/D |
88 |
88 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2015-12-17 |
4 |
B |
$2.00 |
$8,000 |
I/I |
4,000 |
78,375 |
2.58 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
I/I |
74,375 |
74,375 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
